Skip to content
PeptideTech
sign in
live113 compounds · 13 vendors listed · 5 graded · audit of 4 Nov 2026 · prices checked 18 Nov 2026independent · grades can’t be bought

GIP/GLP-1/glucagon triple agonist · GLP-1 · research compound

Retatrutide 30mg for sale: research prices from 2 vendors

investigationalGLP-1
lowest current priceRetatrutide 30mg vial
$229.99$7.67/mg
LA Peptides logoLA Peptidesin stockchecked 14 Nov 2026

For research use only. Price before shipping and tax. Affiliate link: it never affects grades or order.

Retatrutide 30mg vials cost from $229.99 ($7.67/mg) at LA Peptides, observed 14 Nov 2026, and 2 vendors have current prices for this package. Across 5 sizes in stock, prices run from $6.25/mg (48mg) to $10.50/mg (10mg). US-dollar list prices before shipping, tax and unverified codes. These are research-use package prices, not clinic or monthly prescription costs.

Investigational: phase 3 trial results are published, no regulator has approved retatrutide as of 5 Nov 2026, and Lilly plans a US submission in Q1 2027 (a plan, not a launch date).

$229.99lowest 30mg vialLA Peptides
$6.25lowest per mgany size · 2 vendors in stock
$8.50median per mg7 in-stock offers
9lot COAs read3 vendors
Bevidence gradephase 2–3 human trials

ranked by use case · prices read in the last 7 days · no supplier pays for a place

Where to buy Retatrutide 30mg

2 suppliers have Retatrutide in stock at a price read in the last 7 days. PeptideTech names no single best supplier: the list is ranked by price per mg for 30mg, and the leader for each use case is marked.

  • best valueLA Peptides$7.67/mg for 30mg · price read 14 Nov 2026
  • best documentedAmerican Peptidesvendor grade 71/100 · from lab documents and records, never paid
  • most sizes in stockAmerican Peptides4 sizes at a current price
Where to buy Retatrutide: suppliers ranked by price per mg for 30mg, with package, price, vendor grade, sizes in stock, the date each price was read and the supplier link
ranksupplierpackagepriceper mgvendor gradesizes in stockprice readsupplier link
rank 1LA Peptidesbest value1 vial · 30mg labelled$229.99$7.67/mg3 sizesview offer, Retatrutide 30mg at LA Peptides, opens in a new tab
rank 2American Peptidesbest documentedmost sizes1 vial · 48mg labelled no 30mg in stock$300.00$6.25/mg4 sizesview offer, Retatrutide 48mg at American Peptides, opens in a new tabcopies code TECH10

How it is ranked. Suppliers with 30mg in stock come first, cheapest price per mg first; a supplier without it follows with its cheapest current package. Best documented is the PeptideTech vendor grade (rubric v0.6), computed from lab documents, business records and service terms; no supplier can pay for a grade or a place, and the featured partner gets no extra place here. Most sizes counts the sizes in stock at a current price. Prices are listed prices before codes, shipping and tax; a price older than 7 days is left out. how supplier evidence is assessed

sorted by price · 30mg · prices before codes and shipping · checked 17 Nov 2026

Retatrutide 30mg offers

research market · not for human use

These vendors sell compounds as research chemicals. Most are not FDA-approved.

Prices are each vendor’s listed price before shipping, unless a verified code is marked as included. Some outbound links are affiliate links and PeptideTech keeps a fee from sellers on checkout orders; neither affects grades or scores, or order apart from the labelled featured partner. PeptideTech does not test products. Certificates of analysis are the seller’s or the lab’s documents, attributed to them, and PeptideTech does not verify them unless a specific record says so. Report a seller

one exact package · 1 vial · 30mg labelled · US dollars before shipping and tax

Retatrutide 30mg supplier comparison

Retatrutide 30mg offers: package, price, price per mg, status, observation date, code terms and lot certificate
supplierpackageprice (USD)per mgstatusobservedcode termslot certificate
LA Peptides evidence profile1 vial · 30mg labelled$229.99$7.67/mgcurrent · in stock14 Nov 2026no codeBioviridian Inc. · 20 Oct 2026 · lot 1918
American Peptides evidence profile1 vial · 30mg labelled$240.00$8.00/mgcurrent · out of stock17 Nov 2026code TECH10 carried by our link; not deducted (discount unverified)Bioviridian Inc. · 17 Aug 2026 · lot RETA30-0803
Blank Peptides evidence profile1 vial · 30mg labelled$239.00$7.97/mghistorical30 Sep 2026code PEPTECH carried by our link; not deducted (discount unverified)none matched
  • Package. Every row is a single vial (1 vial · 30mg labelled); multi-vial packs, kits and bundles are left off this comparison.
  • Price scope. Each vendor’s listed item price in US dollars for the US market, before shipping and sales tax, which its checkout sets. A code is deducted only when its discount was verified in a cart. These are research-use package prices, not clinic, prescription or monthly programme costs.
  • Current or historical. A price is current when its source was read in the last seven days; historical rows are older listings, kept with their date and left out of the lowest price and the structured data.
How offers are selected
  • Every row is one exact package: 30mg, one form, US market, US-dollar price as the vendor lists it.
  • Vials, multi-vial packs, bundles, pens, sprays and blends stay in separate comparisons; kits and subscriptions are left out.
  • Offers are ranked by displayed price; a code is included only when its discounted price was verified in a cart. A referral code is not a confirmed discount.
  • A price is current when its source was read in the last 7 days; older listings stay visible as historical and are excluded from the lowest price. Read each offer’s source date, stock, currency and market.
  • A catalogue name or alias (a vendor code name) is the seller’s claim: check it against the product specification and the lot report.
  • Grades come from lab documents, business records and service terms, scored the same way for every vendor; no vendor can pay for a grade or rank.

Grading rubric, sources and corrections: how supplier evidence is assessed.

Other packages side by side, with each size’s lowest current price: compare all Retatrutide sizes and suppliers.

every size · lowest current in-stock price · US dollars before shipping

Retatrutide price by size

Retatrutide price by size: lowest current in-stock price, price per mg, vendor, observation date and availability
sizepackagefromper mgcheapest vendorobservedavailability
Retatrutide 10mg price1 vial · 10mg labelled$94.99$9.50/mgLA Peptides14 Nov 20262 in stock
Retatrutide 15mg price1 vial · 15mg labelled————historical · last $119.00 at Blank Peptides, 30 Sep 2026
Retatrutide 20mg price1 vial · 20mg labelled$169.99$8.50/mgLA Peptides14 Nov 20262 in stock
Retatrutide 30mg price this page1 vial · 30mg labelled$229.99$7.67/mgLA Peptides14 Nov 20261 in stock
Retatrutide 48mg price1 vial · 48mg labelled$300.00$6.25/mgAmerican Peptides17 Nov 20261 in stock
Retatrutide 60mg price1 vial · 60mg labelled$400.00$6.67/mgAmerican Peptides17 Nov 20261 in stock

This page compares 30mg; the Retatrutide page compares its default package, and every size opens its own supplier comparison. Prices exclude shipping and tax.

in-stock offers · every size · per mg before codes and shipping

what it costs

Dated observations, daily medians and CSV or JSON downloads for this package: Retatrutide price history and methodology.

this page compares 30mg only

more on Retatrutide

Evidence, lab results, legal status and storage cover every size and are on the Retatrutide page.

short answers

Retatrutide 30mg questions

How much does Retatrutide cost?
Retatrutide 30mg costs from $229.99 across 2 vendors with current prices. The cheapest in-stock offer is LA Peptides at $229.99 ($7.67/mg), observed Nov 14, 2026. Other sizes (10mg, 15mg, 20mg, 48mg, 60mg) are listed in the price-by-size table. Across every size, current in-stock listings run from $6.25/mg (48mg at American Peptides) to $10.50/mg (10mg at American Peptides). These are US-dollar item prices for research-use packages, before shipping, sales tax and unverified codes; they are not the monthly cost of a clinic or prescription programme.
Where is the cheapest place to buy Retatrutide?
LA Peptides has the cheapest in-stock offer among the 2 vendors with current prices for Retatrutide 30mg, at $229.99. “Cheapest” uses the displayed price, including a code only when its discounted price is explicitly verified, and excludes shipping.
Is the Retatrutide 30mg price for one vial or several?
One. Every 30mg offer compared here is a single vial labelled 30mg, so its price per mg is the item price divided by 30mg. Multi-vial packs, kits and bundles are left off the comparison, because a pack is a different unit from one vial. Check the selected option on the vendor’s page before ordering. The listings compared here are research-use-only products sold for laboratory research, not medicines for human use.
How is the Retatrutide 30mg price per mg calculated?
Item price divided by the labelled amount: $229.99 ÷ 30mg = $7.67/mg for the cheapest current offer (LA Peptides, observed Nov 14, 2026). The figure uses the label, not a measured assay: a certificate’s purity or net-content result is reported separately and can differ from the label. Shipping, tax and unverified codes are not included.
What sizes of Retatrutide are available?
Retatrutide is sold in 6 sizes: 10mg, 15mg, 20mg, 30mg, 48mg, 60mg. This page compares the selected package; availability differs by form, size and vendor.
Are the Retatrutide prices and discount codes current?
Each offer shows the date its price was last observed at the vendor (newest for 30mg: Nov 17, 2026); loading the page does not check vendors again. Automated sources run on a schedule and other sources are checked by hand, so dates differ by vendor. A listing not seen for 7 days is marked historical and excluded from current prices (1 listing for 30mg is historical now). A code is deducted from a price only when its discount was verified in a cart; for 30mg, 1 offer carries a code shown before its discount.
Which Retatrutide coupon codes work?
Code PEPTECH is carried by the relevant affiliate link and can be copied separately, but its shopper discount is not deducted because checkout eligibility is unverified. Code TECH10 is carried by the relevant affiliate link and can be copied separately, but its shopper discount is not deducted because checkout eligibility is unverified.
Is Retatrutide FDA approved?
Drugs@FDA lists no NDA, BLA or ANDA with retatrutide as an active ingredient (names searched: RETATRUTIDE, LY3437943; checked October 7, 2026). Research-labelled Retatrutide listings are not FDA-approved drugs. FDA states that retatrutide is not a component of an FDA-approved drug. Lilly describes it as investigational. This review does not infer regulatory status for every country.
Has Retatrutide been tested in clinical trials?
Yes. PeptideTech has matched 34 ClinicalTrials.gov registrations that list Retatrutide as an intervention (Phase 3: 14, Phase 2: 4, Phase 1: 15, Not applicable: 1; checked October 9, 2026; the profile keeps up to 40, active studies first); 11 are active or recruiting, and 2 have posted results. Lead sponsors: Eli Lilly and Company and Hudson Biotech. A registration describes a protocol; it does not report an outcome. PubMed indexes 7 selected human studies in which participants received Retatrutide, most recently “Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial” (Lancet (London, England), 2026). The listings compared here are research-use-only products sold for laboratory research, not medicines for human use.
Is Retatrutide legal to buy?
A research-labelled listing does not establish legal eligibility in every jurisdiction. Product status, purpose, import rules and destination matter. Review the jurisdiction-specific sources in the reference notes; PeptideTech does not provide a worldwide legality determination.
Is the Retatrutide price a clinic or monthly cost?
No. Prices here are research-use packages as suppliers list them: one 30mg vial from $229.99 at LA Peptides. Clinics and prescription services quote monthly programme fees, which can include a consultation, a prescription and pharmacy preparation, set by a clinician’s plan. PeptideTech does not turn a vial price into a monthly figure, because that needs a usage schedule it does not provide, and it gives no medical advice. The listings compared here are research-use-only products sold for laboratory research, not medicines for human use.
Can you purchase retatrutide?
2 research vendors have a current in-stock Retatrutide listing; Retatrutide 10mg costs from $94.99 ($9.50/mg) at LA Peptides, observed Nov 14, 2026. Drugs@FDA lists no approved application with retatrutide as an active ingredient (checked October 7, 2026), so there is no FDA-approved Retatrutide medicine, on prescription or over the counter. The listings compared here are research-use-only products sold for laboratory research, not medicines for human use. Whether a product may be bought, imported or used depends on the jurisdiction, the exact product and its purpose; PeptideTech does not sell products or provide a legality determination.
Do you need a prescription for retatrutide?
Drugs@FDA lists no approved application with retatrutide as an active ingredient (checked October 7, 2026), so there is no FDA-approved Retatrutide medicine, on prescription or over the counter. The listings compared here are research-use-only products sold for laboratory research, not medicines for human use. Whether a product may be bought, imported or used depends on the jurisdiction, the exact product and its purpose; PeptideTech does not sell products or provide a legality determination.
Is retatrutide the same as Ozempic?
No. Ozempic is an FDA-approved prescription medicine whose active ingredient is semaglutide (Drugs@FDA NDA 209637 and NDA 213051, Novo; checked October 7, 2026). Semaglutide has the formula C187H291N45O59 and a molecular weight of 4114 g/mol (PubChem CID 56843331); Retatrutide has the formula C221H342N46O68 and a molecular weight of 4731 g/mol (PubChem CID 171390338). They are different substances. Drugs@FDA lists no approved application with retatrutide as an active ingredient (checked October 7, 2026), so there is no FDA-approved Retatrutide medicine, on prescription or over the counter. PeptideTech compares identity, status and listings, not effects.
What is the price of retatrutide 10mg in the USA?
Retatrutide 10mg costs from $94.99 ($9.50/mg) at LA Peptides, observed Nov 14, 2026, the cheapest of 2 vendors with a current in-stock price for 10mg. Prices exclude shipping. The listings compared here are research-use-only products sold for laboratory research, not medicines for human use.
observed source prices · last 14 days

Retatrutide price history

Daily median and supplier price range: 30mg VialUSD per package. 13 days checked, 11 with an in-stock price, 2 with a median from two or more suppliers. The line joins consecutive days and is broken across longer gaps; missing days are never filled. Daily values are in the table below.$228$230$232$234$236$238$240Nov 5Nov 11Nov 18

Explore full price history, daily medians & downloads →

Actual source observations from the last 14 days, shown separately by supplier, package and currency. Missing days are not filled in. The first refresh can preserve an earlier recorded price; it does not establish a daily price history.

Observed (UTC)SupplierPackagePriceStock
2026-11-17 07:50American Peptides30mg · Vial$240.00Out of stock
2026-11-16 08:02American Peptides30mg · Vial$240.00In stock
2026-11-15 07:50American Peptides30mg · Vial$240.00In stock
2026-11-14 07:51LA Peptides30mg · Vial$229.99In stock
2026-11-14 07:49American Peptides30mg · Vial$240.00In stock
2026-11-13 07:52LA Peptides30mg · Vial$229.99In stock
2026-11-13 07:50American Peptides30mg · Vial$240.00In stock
2026-11-12 07:50American Peptides30mg · Vial$240.00In stock
2026-11-11 07:49American Peptides30mg · Vial$240.00In stock
2026-11-10 07:50American Peptides30mg · Vial$240.00In stock
2026-11-09 07:50American Peptides30mg · Vial$240.00Out of stock
2026-11-08 07:49American Peptides30mg · Vial$240.00In stock

Research reference

Selected sources reviewed

Retatrutide, also identified as LY3437943, is an investigational agonist at GIP, GLP-1 and glucagon receptors. A peer-reviewed phase 2 trial and a later sponsor-described phase 3 program are different levels of source evidence.[1][2]

Identity checks

“Triple agonist” names the three receptor targets; it does not identify a separate “GLP-3” receptor or authenticate a product sold under that nickname.[1][2]

Published phase 2 evidence; phase 3 sponsor updates

The published randomized phase 2 trial enrolled 338 adults. Lilly’s current information describes an investigational phase 3 development program. Sponsor updates are identified as sponsor information, not substituted for a peer-reviewed paper or regulatory approval.[1][2]

Regulatory context

Drugs@FDA lists no NDA, BLA or ANDA with retatrutide as an active ingredient (names searched: RETATRUTIDE, LY3437943; checked October 7, 2026). Research-labelled Retatrutide listings are not FDA-approved drugs.

Sources: Drugs@FDA active-ingredient search: RETATRUTIDE, LY3437943 · checked

FDA states that retatrutide is not a component of an FDA-approved drug. Lilly describes it as investigational. This review does not infer regulatory status for every country.[3][2]

Supporting sources

  1. Retatrutide for obesity: a randomized phase 2 trialNew England Journal of Medicine · PubMed record · checked
  2. What to know about retatrutideEli Lilly and Company · trial sponsor · checked
  3. FDA concerns with unapproved GLP-1 drugs used for weight lossU.S. Food and Drug Administration · checked
Research searches — not supporting citations

Search results may include unrelated records. A search link does not establish that a matching study exists.

These selected sources describe named substances and studied formulations. They do not authenticate a supplier, a certificate of analysis or the contents of a particular lot, and do not provide instructions for use. “Healing” and other catalogue categories are navigation labels, not evidence of efficacy or treatment recommendations.

Understand the evidence

Retatrutide research and reading

Read the evidence, identity checks and limitations alongside the catalogue. Research findings do not verify a vendor’s product or establish suitability for personal use.

Research explainers

Retatrutide Storage: Powder, Solutions & Evidence Limits

What each retatrutide supplier actually states about storing the powder and a solution, what stability evidence exists, and why no shelf life can be taken from other peptides.

4 min read11 primary sources
Updated Nov 5, 2026
Research explainers

Retatrutide Approval Status, Availability & Trial Updates

Is retatrutide FDA approved? A dated status box, the approval-versus-trial timeline, a registry table and the phase 3 papers published so far, with unknowns stated plainly.

6 min read20 primary sources
Updated Nov 5, 2026
Research explainers

Retatrutide, Tirzepatide & Semaglutide: Evidence Compared

A three-way matrix of receptor targets, authorization status and trials, plus which pairs have head-to-head evidence and why separate trial results cannot be ranked.

3 min read17 primary sources
Updated Nov 5, 2026

Save Retatrutide

Bookmark this product in your browser. To keep a particular supplier, size and form, use “Save offer” beside a price. Neither feature sends alerts or creates a subscription.